Home »
Academic Articles & Research Papers
Showing 14 of 14 academic articles
Meng Zhang, Ping He, Zhigang Bian • Frontiers in Molecular Neuroscience
(2021)
Neurodegenerative diseases (NDDs), including Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS), are progressive and ultimately fatal. NDD onset is influenced by several fa...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fnmol.2021.685143
Khushboo Singh, Roon Banerjee, Chandrakanta Potdar, Anisha Shaw et al. • Cells
(2026)
Mutations in leucine-rich repeat kinase 2 (LRRK2) are among the most common genetic causes of Parkinson’s disease (PD), yet substantial heterogeneity exists among pathogenic variants. How mutations in distinct functional domains of LRRK2 di...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/cells15040342
Stewart F. Graham, Nolwen L. Rey, Zafer Ugur, Ali Yilmaz et al. • Metabolites
(2018)
For people with Parkinson’s disease (PD), considered the most common neurodegenerative disease behind Alzheimer’s disease, accurate diagnosis is dependent on many factors; however, misdiagnosis is extremely common in the prodrom...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/metabo8040071
Majed Alluqmani, Abdulfatah M. Alayoubi, Jamil A. Hashmi, Jamil A. Hashmi et al. • Frontiers in Genetics
(2024)
BackgroundVariants in a gene encoding sodium voltage-gated channel alpha subunit 1 (SCN1A) are known to cause a broad clinical spectrum of epilepsy and associated features, including Dravet syndrome (MIM 607208), non-Dravet developmental an...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fgene.2024.1496683
Lufei Chen, Chaoxian Dai, Zhenfang Wu, Yuhan Lin et al. • Journal of Xenobiotics
(2026)
Accumulating epidemiological evidence links ambient PM2.5 exposure to elevated Parkinson’s disease (PD) risk, yet the neurotoxicity triggered by PM2.5 multi-pollutant mixtures under real co-exposure scenarios remains insufficiently elucidat...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/jox16060184
Emma A. Honkanen, Mikael Eklund, Simo Nuuttila, Tommi Noponen et al. • NeuroImage: Clinical
(2021)
Objective: To evaluate possible differences between brain dopamine transporter (DAT) binding in a group of symptomatic parkinsonism patients without dopaminergic degeneration and healthy individuals. Background: Dopaminergic neuroimaging st...
DOAJ
Open Access (DOAJ)
DOI: 10.1016/j.nicl.2021.102807
Quoc Cuong Ngo, Nicole McConnell, Mohammod Abdul Motin, Barbara Polus et al. • IEEE Journal of Translational Engineering in Health and Medicine
(2024)
Objective: A change in handwriting is an early sign of Parkinson’s disease (PD). However, significant inter-person differences in handwriting make it difficult to identify pathological handwriting, especially in the early stages. Thi...
DOAJ
Open Access (DOAJ)
DOI: 10.1109/JTEHM.2024.3355432
Ruichen Su, Tian Zhou • Frontiers in Aging Neuroscience
(2021)
Parkinson’s disease (PD) is a neurodegenerative disorder closely related to immunity. An important aspect of the pathogenesis of PD is the interaction between α-synuclein and a series of immune cells. Studies have shown that accumulation of...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fnagi.2021.769506
Nanxia Zhao, Nicola L. Francis, Shuang Song, Vladyslav Kholodovych et al. • Advanced NanoBiomed Research
(2022)
Neuroinflammation is one of the hallmarks contributing to Parkinson's disease (PD) pathology, where microglial activation occurs as one of the earliest events, triggered by extracellular α‐synuclein (aSYN) binding to the cluster of differen...
DOAJ
Open Access (DOAJ)
DOI: 10.1002/anbr.202100120
Md Fahim Anjum, Arturo I. Espinoza, Rachel C. Cole, Arun Singh et al. • npj Parkinson's Disease
(2024)
Abstract Cognitive dysfunction is common in Parkinson’s disease (PD). We developed and evaluated an EEG-based biomarker to index cognitive functions in PD from a few minutes of resting-state EEG. We hypothesized that synchronous changes in ...
DOAJ
Open Access (DOAJ)
DOI: 10.1038/s41531-023-00602-0
Aleš Kopal, Eva Mejzlíková, Jana Lízrová Preiningerová, David Brebera et al. • Parkinson's Disease
(2015)
Parkinson’s disease (PD) is characterized by motor and nonmotor symptoms. Nonmotor symptoms include primarily visual hallucinations (VH). The aim of our study was to establish whether patients with PD and visual hallucinations (PDH+) have s...
DOAJ
Open Access (DOAJ)
DOI: 10.1155/2015/709191
Liaqat Ali, Ce Zhu, Noorbakhsh Amiri Golilarz, Ashir Javeed et al. • IEEE Access
(2019)
Parkinson's disease (PD) is the second most common neurodegenerative disease of central nervous system (CNS). Till now, there is no definitive clinical examination that can diagnose a PD patient. However, it has been reported that PD patien...
DOAJ
Open Access (DOAJ)
DOI: 10.1109/ACCESS.2019.2932037
Pengsheng Hui, Yu Jiang, Jie Wang, Congxiao Wang et al. • Frontiers in Aging Neuroscience
(2024)
BackgroundParkinson’s disease (PD) is a prevalent neurodegenerative disorder that significantly benefits from early diagnosis for effective disease management and intervention. Despite advancements in medical technology, there remains a cri...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fnagi.2024.1354147
Morales-de-Arcia AA, Lázaro-Figueroa A, Caballero-Sánchez U, De-Anda-Moctezuma G et al. • Aging clinical and experimental research
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1007/s40520-026-03448-7
PMC: PMC13736315